HomeInsightsMarket Capitalization

Market Capitalization of Gland Pharma Ltd

Market Capitalization of Gland Pharma Ltd

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

7.6 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Gland Pharma Ltd

NSE: GLAND

MARKETCAP

30353.03 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Gland Pharma Ltd is ₹ 30353 crore as of 18 Sep 24.
  • The Market Cap of Gland Pharma Ltd changed from ₹ 40535 crore on March 2020 to ₹ 30338 crore on March 2024 . This represents a CAGR of -6.99% over 4 years. .
  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1842 as of 18 Sep 15:30.

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Gland Pharma Ltd

No data available

Image

Gland Pharma Ltd

NSE: GLAND

PRICE

1842.35

-4.70 (-0.25%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20241842.35
17 Sep 20241847.05
16 Sep 20241865.5
13 Sep 20241877.6
12 Sep 20241889.35
11 Sep 20241889.75
10 Sep 20241927.1
09 Sep 20241902.6
06 Sep 20241904.85
05 Sep 20241890.95

SWOT Analysis Of Gland Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gland Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gland Pharma Ltd4230,353
Sun Pharmaceuticals Industries Ltd414,39,714
Divis Laboratories Ltd861,45,166
Cipla Ltd301,33,402
Torrent Pharmaceuticals Ltd681,13,724
Dr Reddys Laboratories Ltd191,09,604

Key Valuation Metric of Gland Pharma Ltd

No data available

Historical P/E Ratio of Gland Pharma Ltd

No data available

* All values are in %

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gland Pharma Ltd

No data available

* All values are in %

About Gland Pharma Ltd

  • Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994 and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act, 1956.
  • The Company is primarily engaged in manufacturing injectable formulations.
  • The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.

Gland Pharma Ltd News Hub

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

07 Aug 202411:27

News

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspec...

Read more

05 Aug 202412:19

News

USFDA conducts surprise inspection of Gland Pharma's Dundigal facility

Gland Pharma announced that the United States Food and Drug Administration (US FDA) has co...

Read more

25 Jul 202413:49

News

Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received tentative approval from the United States Food and Drug Administ...

Read more

24 Jul 202410:09

News

Gland Pharma schedules board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 6 August 2024...

Read more

20 Jul 202412:06

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Gland Pharma Ltd

What is the market cap of Gland Pharma Ltd?

As of September 18, 2024, Gland Pharma Ltd has a market capitalization of ₹30353.03, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Gland Pharma Ltd's market capitalization?

Gland Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Gland Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Gland Pharma Ltd's market capitalization change?

Gland Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*